Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
02/01/2006 | EP1620110A2 Immunomodulator phosphonate conjugates |
02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
02/01/2006 | EP1537082A4 Processes for the preparation of s-(-)-amlodipine |
02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
02/01/2006 | CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics |
02/01/2006 | CN1729188A Synthesis of heteroaryl acetamides |
02/01/2006 | CN1729178A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
02/01/2006 | CN1239503C Liquid crystalline-3, 4:9, 10-perylenetetracarboxylic acid diimides |
01/31/2006 | US6992205 Process for the production of sulfonic esters |
01/31/2006 | US6992190 Hydroxamic acid derivatives as antibacterials |
01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
01/31/2006 | US6992090 Substituted piperidine compounds and methods of their use |
01/31/2006 | CA2433193C Amide derivative of amlodipine |
01/30/2006 | CA2514000A1 Fexofenadine base polymorphic forms |
01/26/2006 | WO2006008260A1 Dimeric piperidine derivatives |
01/26/2006 | WO2006008259A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
01/26/2006 | WO2006008029A1 Shortened method for the production of l-lobeline |
01/26/2006 | WO2005105766A3 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |
01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
01/26/2006 | US20060020135 Long chain aliphatic alcohol derivatives and methods of making and using same |
01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
01/26/2006 | US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
01/26/2006 | US20060019995 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same |
01/26/2006 | US20060019992 Cycloalkylamine derivatives as NK-1/SSRI antagonists |
01/26/2006 | US20060019941 Prophylaxis or prevention of aberrations in a signal transduction pathway mediated by a cKit kinase by administering 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
01/26/2006 | US20060019939 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
01/26/2006 | US20060019358 Bioconversion of terfenadine with a microorganism culture of Absidia corymbifera to obtain a racemic mixture of fexofenadine; specificity of the bioconversion with these microorganisms, good yield and little or no by-products |
01/26/2006 | DE19754322B4 Verfahren zur Herstellung von Salzen cyclischer Amidine A process for the preparation of salts of cyclic amidines |
01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
01/26/2006 | CA2572822A1 Dimeric piperidine derivatives |
01/26/2006 | CA2572821A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders |
01/25/2006 | EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
01/25/2006 | EP1618087A2 Antibacterial agents |
01/25/2006 | EP1617848A2 Anti-cancer phosphonate conjugates |
01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |
01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
01/25/2006 | CN1726193A Heterocyclic selective androgen receptor modulators and methods of use thereof |
01/25/2006 | CN1726192A 3-amino-piperadine derivatives and methods of manufacture |
01/25/2006 | CN1238342C Novel amlodipine camsylate and method for preparing thereof |
01/24/2006 | US6989449 Containing nitroxide or hydroxylamine moieties; use stabilizing pulp or paper against yellowing and discoloration due to light |
01/24/2006 | US6989448 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
01/24/2006 | US6989402 Thyroid receptor ligands and method II |
01/24/2006 | US6989394 Tetrahydropyridines |
01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
01/24/2006 | CA2433366C Amlodipine free base |
01/24/2006 | CA2292984C Ccr5 modulators |
01/19/2006 | WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
01/19/2006 | US20060014961 Processes for the preparation of s-(-)-amlodipine |
01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
01/19/2006 | US20060014804 Cyanoguanidine prodrugs |
01/19/2006 | US20060014795 S-(-) -amlodipine nicotinate and process for the preparation thereof |
01/19/2006 | US20060014793 Process and diastereomeric salts useful for the optical resolution of racemic alpha-(4-(1, 1-dimethylethyl) phenyl] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol and derivative compounds |
01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
01/19/2006 | US20060014791 Process for manufacturing of chiral lobelin |
01/19/2006 | US20060014789 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
01/19/2006 | US20060014731 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
01/19/2006 | US20060013852 Use of organic compounds |
01/19/2006 | US20060011886 Liquid crystal mixture |
01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
01/18/2006 | EP1616861A2 A process for the preparation of keto compounds |
01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
01/18/2006 | EP1615909A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
01/18/2006 | EP1615890A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
01/18/2006 | EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
01/18/2006 | EP1615878A2 Compounds, compositions and methods |
01/18/2006 | EP1615866A1 Indene derivatives as pharmaceutical agents |
01/18/2006 | EP1615643A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
01/18/2006 | EP1432683B9 Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation |
01/18/2006 | EP0973727B8 Activated iododerivatives for the treatment of cancer and aids |
01/18/2006 | CN1723199A 1,4-disubstituted piperidine derivatives and their use as 11-beta hsd1 inhibitors |
01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
01/17/2006 | US6987199 comprises activation of zinc metal in situ by adding catalytic amount of hydrochloric/sulfuric acid; for use as intermediate in synthesis of quinoline antibiotics (Ciprofloxacin, Levofloxacin, Gemifloxacin, and Trovafloxacin) |
01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
01/17/2006 | US6987111 Aripiprazole, olanzapine and haloperidol pamoate salts |
01/17/2006 | US6986833 For the preparation of dimethylpropylamine from dimethylamine and propionaldehyde in the presence of hydrogen |
01/17/2006 | CA2218921C Preparation of a crystalline solid from glycine-n,n-diacetic acid derivatives with sufficiently low hygroscopicity |
01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
01/12/2006 | WO2006004793A2 Hetero isonipecotic modulators of vanilloid vr1 receptor |
01/12/2006 | WO2006003494A2 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides |
01/12/2006 | WO2006002956A1 Piperidine derivatives and their use as glycine transporter inhibitors |
01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
01/12/2006 | US20060009491 Amido compounds and their use as pharmaceuticals |
01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
01/12/2006 | CA2572874A1 Urea derivative |
01/12/2006 | CA2572075A1 Hetero isonipecotic modulators of vanilloid vr1 receptor |
01/12/2006 | CA2568808A1 Chemical compounds |
01/11/2006 | EP1614681A1 Fexofenadine polymorphs and process for the preparation thereof |
01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |